NEUROGEN FILES FOR 2 MILLION-SHARE OFFERINGNeurogen Corp. has filed for an offering of 2 million shares ofcommon stock. Following the offering, Neurogen will have 7.8million shares outstanding. Underwriters Allen & Co. Inc. ofNew York have an option to buy an additional 300,000 sharesto cover overallotments. Proceeds will be used to fund researchand development and for working capital and generalcorporate purposes. Neurogen is developing therapeutics totreat psychiatric and neurological disorders. Shares of theBranford, Conn.-based company (NASDAQ:NRGN) closed at $6 onTuesday, up $1.
TOYOBO LICENSES AT BIOCHEM'S POLYMERS
AT Biochem of Malvern, Pa., has closed a strategic distributionalliance with Toyobo Biochemicals of Osaka, Japan. In return foran undisclosed fee, Toyobo will license and exclusively sell inJapan, Taiwan and Korea AT Biochem's proprietary HydroLinkpolymers used in DNA sequencing and enzyme digest gels.Within the past year, privately held AT Biochem signed asimilar exclusive distribution partnership with BoehringerIngelheim in Germany, and a co-exclusive with J.T. Baker in theUnited States.
TSI TO INCLUDE STOCK IN NASDAQ EXPANSION
TSI Corp. (NASDAQ:TSIN) of Worcester, Mass., on Tuesdayannounced that its stock will be included in the expansion June4 of National Market System list of the NASDAQ securities. Theticker symbol will be unchanged. TSI develops animal diseasemodels and animal strains capable of producing pharmaceuticalproteins.
(c) 1997 American Health Consultants. All rights reserved.